Duprex, William Paul
- Icahn School of Medicine at Mount Sinai · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #19,679
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$614.8K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#19,679
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Duprex, William Paul as a PI. Multi-PI records show the full award amount for context.
- 7R01AI163011-02R01Contact PIDevelopment of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralizationIcahn School of Medicine at Mount Sinai · Pharmacology (NIH department code)$614.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Duprex, William Paul as a PI.
FY2023 award administered by Icahn School of Medicine at Mount Sinai (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardIcahn School of Medicine at Mount Sinai
- 2022$500K Cumulative Funding
- 2022R01 Grant Holder
- 2023$1M Cumulative Funding